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Micro-abstract:  
The optimal exercise intensity and frequency to promote clinically significant improvements in 
cardiorespiratory fitness and body composition for colorectal cancer survivors is unknown. In a group of 
colorectal cancer survivors (n=57), high intensity interval exercise promoted superior benefits to the current 
moderate intensity exercise guidelines, even with a substantially reduced training frequency and following 
short-term training withdrawal. 
 
Abstract:  
Introduction: Deteriorations in cardiorespiratory fitness (V̇O2peak) and body composition are associated with 
poor prognosis following colorectal cancer treatment. However, the optimal intensity and frequency of aerobic 
exercise training to improve these outcomes in colorectal cancer survivors is unknown. Methods: This trial 
compared eight weeks of moderate intensity continuous exercise [MICE; 50min; 70% peak heart rate (HRpeak); 
24 sessions], with high intensity interval exercise (HIIE; 4x4min; 85-95% HRpeak) at an equivalent (HIIE; 24 
sessions) and tapered frequency (HIIE-T; 16 sessions) on V̇O2peak, lean and fat mass, measured at baseline, 
four, eight and twelve weeks. Results: Increases in V̇O2peak were significantly greater following both four 
(+3.0ml·kg-1·min-1, p=0.008) and eight (+2.3ml·kg-1·min-1, p=0.049) weeks of HIIE compared with MICE. 
After eight weeks, there was a significantly greater reduction in fat mass after HIIE compared to MICE (-0.7kg, 
p=0.038). Four weeks following training, the HIIE group maintained elevated V̇O2peak (+3.3ml·kg-1·min-1, 
p=0.006) and reduced fat mass (-0.7kg, p=0.045) compared to the MICE group, with V̇O2peak in the HIIE-T 
also being superior to the MICE group (+2.8ml·kg-1·min-1, p=0.013). Conclusions: Compared to MICE, HIIE 
promotes superior improvements and short-term maintenance of V̇O2peak and fat mass improvements. HIIE 
training at a reduced frequency also promotes maintainable cardiorespiratory fitness improvements. In addition 
to promoting accelerated and superior benefits to the current aerobic exercise guidelines, HIIE promotes 
clinically relevant improvements even with a substantial reduction in exercise training and for a period 
following withdrawal.  
 
Clinical Practice Points 
What is already known about this topic?  
There is a strong relationship between cardiorespiratory fitness, body composition and clinical prognosis 
following colorectal cancer. Whilst exercise has been shown to improve these outcomes, the optimal intensity 
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and frequency of exercise to maximise clinically relevant improvements for colorectal survivors remains to be 
determined. 
What are the new findings? 
When compared to the current aerobic guidelines (moderate intensity continuous exercise), eight weeks of high 
intensity interval exercise (HIIE) promoted accelerated and superior improvements in cardiorespiratory fitness 
and reductions in fat mass. Importantly following complete withdrawal of the training intervention for four 
weeks, participants who completed HIIE maintained these improvements without an additional training 
stimulus. Furthermore, a tapered HIIE training program (training frequency reduced by two-thirds for the latter 
half of the intervention) was sufficient to maintain superior increases in cardiorespiratory fitness following 
training cessation relative to the group prescribed the current guidelines.  
How might it impact clinical practice in the future? 
Collectively the results of this investigation suggest that in addition to promoting accelerated and superior 
benefits to the current moderate intensity exercise guidelines in colorectal cancer survivors, HIIE can also 
promote clinically relevant improvements even with a substantial reduction in exercise training and for a period 
following complete training withdrawal. This finding is particularly important given the difficulties promoting 
long-term adherence to exercise programs in cancer survivors; these results suggest that HIIE may be a novel 
approach to promote health-related improvements with a substantially reduced time commitment in colorectal 
cancer survivors.   
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Introduction 
Deteriorations in cardiorespiratory fitness 1-3 and body composition (decreases in lean mass 4 and increases in fat 
mass 5, 6) are independently associated with poor prognosis following colorectal cancer diagnosis and treatment. 
Substantial reductions in V̇O2peak have been shown to predict both morbidity 1 and cancer-specific mortality 2, 
3
. Specific to the musculoskeletal system, decreased lean muscle mass is a prevalent comorbidity following 
colorectal cancer diagnosis that can predict rates of disease-free and overall survival 4. Decreases in muscle 
mass are often masked by increases in fat mass 7, which is independently associated with a range of adverse 
clinical outcomes, including lower overall survival in colorectal cancer patients 5, 6. Cardiorespiratory fitness and 
body composition are thus clinically important prognostic measures that significantly predict long-term 
outcomes for survivors.  
Given the substantial impairments in cardiorespiratory fitness and body composition following treatment for 
colorectal cancer, there is a clear need for effective interventions to ameliorate these deteriorations. Though 
aerobic exercise training improves V̇O2peak, which can subsequently improve prognosis 8, meta-analyses show 
that longer-term (>8 weeks) interventions of moderate-to-vigorous intensity exercise training promote only 
modest (+2.9ml·kg-1·min-1) V̇O2peak improvements in cancer survivors 9. In comparison to moderate intensity 
continuous exercise (MICE), high intensity interval exercise (HIIE) has been shown to offer superior 
cardiorespiratory fitness improvements in healthy adults 10 and patients with lifestyle-induced cardiometabolic 
disease 11. Potential similar relationships between exercise intensity and changes in cardiorespiratory fitness and 
body composition in cancer survivors have revealed no clear consensus regarding the superiority of any specific 
exercise intensity 12-16. As with any novel therapeutic prescription, defining the optimal exercise intensity to 
promote clinically relevant improvements in cardiorespiratory fitness and body composition should encompass 
factors beyond the magnitude of change, to include the time-course and reversibility of changes in response to 
the prescription, with the latter factors yet to be fully investigated in cancer survivors. To date, studies 
examining the influence of exercise intensity on variables in cancer survivors have only compared pre- and post-
training measures; the time-course of these changes have not been evaluated. Equivalent long term changes 
between HIIE and MICE 13-15 does not preclude differences existing between the rates of physiological 
adaptation, as we have previously shown that HIIE promotes improvements in V̇O2peak and reductions in fat 
mass in response to short term training (four weeks) in colorectal cancer survivors 12. Elucidation of potential 
differences in the velocity of adaptations provides important information regarding the duration of prescription 
required for improvements in response to exercise at different intensities. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 6
In addition to the effectiveness in reversing the adverse changes following colorectal cancer, interventions also 
need to promote engagement by considering common barriers to participation in exercise programs. A ‘lack of 
time’ for exercising, when coupled with cancer-specific factors such as fatigue 17, emphasises the need to 
identify exercise interventions that can maximise the clinical benefits of exercise for colorectal cancer survivors 
whilst minimising barriers to participation due to social or disease-specific factors. The concept of tapering or 
reducing training volume (via reduction in exercise frequency, intensity or duration) is widely used to optimise 
athletic performance 18 and to maintain improvements in V̇O2peak 19. Tapering may also be time-effective in the 
oncology setting, where improvements following an initial high-frequency loading period can be effectively 
maintained with a reduced training frequency. This may promote increased adherence to longer-term exercise 
programs due to the reduced training load and time commitment.  
In addition to the within-intervention time course of changes, recent data suggest that supervised higher 
intensity exercise leads to more maintainable improvements in V̇O2peak when continued with a home-based 
prescription compared to MICE 15. However whether adaptations are maintained at all following complete 
withdrawal of the training stimulus in response to differential exercise intensities is yet to be assessed. 
Establishing the magnitude and rate at which adaptations are lost will provide insight into whether exercise-
induced improvements can be at all maintained when interruptions to longer term exercise programs occur, such 
as through non-adherence, clinical complications or social interruptions (e.g. travel). 
The purpose of this study was to describe the time course of changes in cardiorespiratory fitness and body 
composition in responses to an eight-week (1) MICE intervention, (2) HIIE intervention of equivalent 
frequency, and (3) a HIIE intervention utilising a tapered frequency prescription in a cohort of colorectal cancer 
survivors. Short-term maintenance of these changes over four weeks was then assessed following withdrawal of 
the training interventions. It was hypothesised that when compared with MICE, both HIIE prescriptions would 
elicit greater improvements in V̇O2peak and body composition, and that these changes would be less reversible 
in the short-term following training completion.  
Methods 
This study was granted ethical approval by the Human Ethics Committee of The University of Queensland and 
is registered under the Australian and New Zealand Clinical Trials Registry (ACTRN12615000908538; 
www.anzctr.org.au). This study presents the entire approved trial and adds to data previously reported elsewhere 
12
, which was subsequently expanded since the time of publication.  
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Participants 
Men and women previously diagnosed with colorectal cancer were recruited from Brisbane (Queensland, 
Australia) for this randomised controlled trial. Inclusion criteria were as follows: (i) aged ≥18 years old; (ii) ≥ 
one-month post-treatment for colorectal cancer and not anticipating undergoing treatment during the study 
period; and (iii) free of any musculoskeletal, neurological, respiratory, metabolic or cardiovascular conditions 
that may have prevented safe completion of the exercise demands of the study. Details of the recruitment 
processes have been reported elsewhere 12.  
Study Protocol 
Participants were required to obtain physician consent for participation in the program, and were individually 
screened via a medical history form and interview with the investigators to determine eligibility. At the first 
session, participants were provided with further details of the research program and afforded the opportunity to 
seek clarification relating to any aspects of the study, after which informed consent was obtained from all 
individual participants included in the study. Following this, participants completed a familiarisation session 
consisting of a test of peak oxygen consumption (V̇O2peak) to assess cardiorespiratory fitness. Seven days later, 
each participant completed a baseline testing session consisting of an assessment of body composition and a 
V̇O2peak test. Prior to each testing session, participants were asked to: (i) consume plenty of water; (ii) abstain 
from caffeine and alcohol intake for 12 hours; and (iii) avoid any high, vigorous, or unaccustomed moderate 
intensity physical activity for 48 hours. External weekly physical activity behaviours of participants were 
measured at baseline using the Godin leisure-time exercise questionnaire 20. Following baseline testing, a 
researcher independent to the study stratified the participants according to age (<55 or ≥55 years) and sex, and 
randomised participants via a computer generated random number assignment process to one of three groups: 
(1) MICE, (2) HIIE or (3) HIIE-tapered (HIIE-T). All groups trained three times per week for the initial four 
weeks. For the subsequent four-week period, the HIIE and MICE groups continued to train three times per 
week, whereas the HIIE-T group trained once a week. Mid- and endpoint testing, involving identical procedures 
to those used at baseline testing, was completed between three and seven days after four and eight weeks of 
training, respectively. All participants were instructed to maintain their normal diet and physical activity 
behaviours throughout the eight-week intervention, as well as for the four weeks immediately following the 
intervention when the specific training sessions prescribed were ceased. Participants were then re-tested four 
weeks following cessation of the eight-week interventions.  
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Outcome measures 
V̇O2peak testing was completed using a cycle ergometer (Lode Excalibur Sport, Lode B.V., Groningen, 
Netherlands) and a portable metabolic cart system (ParvoMedics TrueOne 2400, Sandy, USA). Following a 
four-minute warm up at 50W, participants cycled at 60-70 revolutions.min-1 with incremental 20-30W.min-1 
increases in resistance until volitional fatigue. V̇O2peak was recorded as the mean of the two highest 15-second 
V̇O2 epochs. Full details of this test have been reported elsewhere 12.  
Subtotal (whole body minus the head) fat and lean masses were measured by dual energy x-ray absorptiometry 
(DXA; Hologic Discovery A, Waltham, MA). The coefficients of variation values in our laboratory for whole 
body fat and lean mass are <1.1%. Scans were conducted and analysed by two accredited DXA technicians; 
inter-tester analysis CV: subtotal fat mass=0.4%; subtotal lean mass=0.3%; subtotal body fat percentage=0.4%). 
Due to equipment malfunction a subset of baseline DXA scans were unavailable for 10 participants who were 
subsequently excluded from body composition analysis. Height and body mass were measured using a 
stadiometer (Seca, Birmingham, United Kingdom) and electronic scales (A & D Mercury, Pty Ltd, Thebarton, 
Australia), respectively.   
Exercise Interventions 
The MICE training protocol consisted of 50 minutes of cycling at 50-70% peak heart rate (HRpeak). The 
frequency and volume of MICE was consistent with the current aerobic physical activity guidelines for cancer 
survivors 21, 22. HIIE training sessions involved a 10 minute warm up at 50-70% HRpeak before the 
commencement of a four minute interval, cycling at 85-95% HRpeak. Each interval was interspersed with a three 
minute period of active recovery,
 
repeated four times for a total of 38 minutes for the session. Intervention 
feasibility (completion rates), safety (adverse events) and adherence were calculated as previously described 12.  
Statistical Analysis 
As the aim of this trial was to investigate efficacy outcomes, a per protocol approach was utilised rather than 
intention to treat. ll data were analysed using SPSS (version 23.0; Chicago, IL). Linear mixed (fixed and 
random) modelling was used to assess changes over time and differences among intervention groups. Group, 
time, and group by time interaction were treated as fixed factors; participants were treated as a random factor 
with individual intercepts. Each model included sex as a covariate and was adjusted using the baseline value as 
a fixed continuous covariate as previously described 23, 24. Model residuals were formally assessed for normality 
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by use of the Shapiro-Wilk test and visual inspection of histogram plots. Bonferroni pairwise adjustments were 
made for all subsequent comparisons. Statistical significance was set at an alpha of p<0.05.  
Results 
Participant flow through the intervention and characteristics for the 57 participants are reported in Figure 1 and 
Table 1, respectively. Details of the most commonly cited reasons for non-participation reported by eligible 
participants are also presented in Figure 1. Fewer women were randomised to the HIIE group (27.8%) compared 
to the HIIE-T (50.0%) and MICE (52.6%) groups. To account for any potential influence of this imbalance, all 
analyses included sex as a covariate, however it was not a significant (p≥0.05) factor in any of the analyses. 
Intervention completion rates for participants within the HIIE, HIIE-T and MICE groups were 94.7%, 95.0% 
and 89.5%, respectively. A total of four participants withdrew prior to the completion of the intervention period 
(8 week time point) due to personal reasons (n=1), family commitments (n=2) or due to ongoing interruptions 
resulting from additional medical diagnostic testing for an unrelated condition (n=1). Seven participants were 
unable to be assessed at the follow up time point (within the stipulated 4±1 week timeframe) following 
completion of the intervention and therefore these data were absent at the 12-week time point. As assessed by 
the Godin questionnaire, there were no significant effects of group allocation (p=0.203), time point (p=0.736) or 
an interaction between these factors (p=0.898) on the exercise frequency index, weighted for the perceived 
intensity of the session. There were no severe adverse events as a result of exercise testing or training, and no 
additional adverse events to those previously detailed 12. 
Cardiorespiratory fitness 
Changes in V̇O2peak are displayed in Table 2. Both HIIE and HIIE-T showed superior increases in V̇O2peak 
after just 4 weeks of training compared to the MICE group at this time point (HIIE vs. MICE: +3.0ml·kg-1·min-
1
, p=0.008; HIIE-T vs. MICE: +2.3ml·kg-1·min-1, p=0.030). Improvements in V̇O2peak after eight weeks of 
HIIE were significantly greater than the improvements following MICE (+2.3 ml·kg-1·min-1, p=0.049). 
Following the four-week withdrawal of the training stimulus, V̇O2peak in the HIIE and HIIE-T groups remained 
significantly higher than the MICE group (HIIE: +3.3ml·kg-1·min-1, p=0.006; HIIE-T: +2.8ml·kg-1·min-1, 
p=0.013). There were no significant (p≥0.05) differences between the HIIE and HIIE-T groups at any time 
point.  
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Body composition 
Lean mass and fat mass changes in response to each intervention are shown in Table 3. There were no 
significant (p≥0.05) between or within-group changes in lean mass for any group across the eight weeks of 
training. Following removal of the training stimulus, there was a significant increase in lean mass in the MICE 
group (+0.2kg, p=0.027), however this was not significantly different from either of the HIIE groups. The HIIE 
group demonstrated a significantly superior decrease in fat mass compared to the MICE group after eight weeks 
of training (-0.7kg, p=0.038) and this was maintained following four weeks without training (-0.7kg, p=0.045).  
Discussion 
This study compared the time course of changes in cardiorespiratory fitness (V̇O2peak) and body composition 
between HIIE and MICE, and the maintenance of these adaptations following a tapered training frequency as 
well as training cessation in colorectal cancer survivors. Compared to MICE (which aligns with current aerobic 
exercise-oncology guidelines), HIIE promoted superior improvements in V̇O2peak and reductions in fat mass 
following eight weeks of training. Relative to the MICE intervention, which had regressed to baseline following 
four weeks without training, superior V̇O2peak and fat mass changes were maintained in the HIIE group.  
Additionally, following withdrawal of the training intervention, V̇O2peak in the HIIE-T group also remained 
significantly elevated above the MICE group indicating improvements accrued following an initial high load 
HIIE prescription were maintained with a substantially reduced training requirement. In addition to the superior 
V̇O2peak and fat mass changes, these preliminary results indicate that prescription of HIIE for colorectal cancer 
survivors may also prevent regression of these adaptations during interruptions to longer term exercise-medicine 
programs and improve adherence due to the propensity for improvements in V̇O2peak with reduced training 
frequency. 
The magnitude of V̇O2peak improvement (+2.7ml·kg-1·min-1) following MICE, which equated to the aerobic 
component of the current physical activity guidelines for cancer survivors, was consistent with the 
improvements reported from a meta-analysis of predominantly moderate-to-vigorous intensity trials in cancer 
patients and survivors 9. In comparison, the improvements from baseline following eight weeks of equivalent 
frequency HIIE training (+5.2ml·kg-1·min-1) were significantly greater (p=0.049), with the velocity of 
adaptation also being superior in the HIIE group. No changes in V̇O2peak were observed after four weeks of 
MICE, whereas significant increases (+4.2ml·kg-1·min-1, p<0.001) constituting 81% of the total improvement in 
V̇O2peak occurred with HIIE during the initial four weeks, indicating accelerated V̇O2peak improvements in 
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response to short term HIIE. This finding confirms the efficacy of HIIE in producing rapid and significant 
improvements in cardiorespiratory fitness.  
Lower levels of V̇O2peak are associated with elevated rates of cancer-specific mortality 2, 3. Increasing 
cardiorespiratory fitness has been associated with significant reductions in cancer-specific mortality, which 
underscores the importance of the present findings 8. Given the breadth of physiological impairments (cardiac 
output, endothelial and skeletal muscle function) following colorectal cancer diagnosis and treatment, it is not 
surprising that such a strong relationship with mortality exists given that V̇O2peak measures the integrated 
maximal function of these systems in response to exercise 25. To contextualise the magnitude of the present 
V̇O2peak changes and their potential clinical relevance, data from the Cooper Center Longitudinal Study (n = 
13,949) estimated that each 1-metabolic equivalent (MET; equivalent to 3.5 ml.kg-1.min-1) increase in 
cardiorespiratory fitness in a population of cancer patients was associated with a 10% [Hazard ratio=0.90 (0.84–
0.97)] reduction in cancer-specific mortality and a 25% [Hazard ratio=0.75 (0.66–0.87)] reduction in the risk of 
cardiovascular disease mortality 3. Additional data from the Aerobics Center Longitudinal Study (n = 13,930) 
reported similar relationships (albeit non-significant) between changes in cardiorespiratory fitness following 
diagnosis (rather than baseline values) 8. A linear relationship was found between improvements in maximal 
METs and reduction in cancer specific mortality (p = 0.05), with each 1-MET increase being marginally 
associated with a 5% reduction in mortality (p = 0.10) 8. Whilst it is not possible to directly estimate the 
potential magnitude of mortality risk reduction, the degree of V̇O2peak improvement after HIIE completed three 
times per week (HIIE = +5.2 ml.kg-1.min-1) or even at a tapered frequency (once per week; HIIE-T = +4.1 ml.kg-
1
.min-1) is likely to be clinically meaningful. Additionally, even following a 4-week withdrawal of the 
prescribed exercise, participants in both HIIE groups maintained their previous increases in V̇O2peak 
(HIIE=+4.2ml·kg-1·min-1; HIIE-T=+3.4ml·kg-1·min-1). Therefore including HIIE as part of exercise-medicine 
programs may provide substantial flexibility in programming frequency when promoting long-term maintenance 
of improvements in V̇O2peak. This includes the capacity to account for interruptions to exercise programs (e.g. 
clinical complications or travel) that may prevent either total or high frequency exercise participation without a 
complete regression of V̇O2peak improvements. In contrast, the present data indicate that whilst eight weeks of 
MICE significantly improves V̇O2peak (2.7ml·kg-1·min-1), longer duration MICE programs may be necessary to 
achieve improvements associated with clinically relevant reductions in mortality. This necessitates that 
programs primarily focusing on the prescription of MICE (as per the current aerobic exercise guidelines for 
cancer survivors) require inclusion of strategies to promote long term exercise adherence to enable clinically 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 12
meaningful changes to be achieved and that greater attention is given to avoiding periods of non-adherence to 
sustain elevated V̇O2peak levels.  
Previous studies in cancer survivors have generally not found higher intensity exercise to offer superior 
improvements in V̇O2peak above moderate intensity exercise 13-16. However, this may be due to the considerable 
heterogeneity amongst the high-intensity prescriptions used in these studies. High intensity interval exercise 
allows for increases in the duration of exercise spent at high workloads via regular recovery periods, and can be 
manipulated based on several variables (including work/recovery intensity, duration of interval/recovery, 
repetition number) 26. It is generally thought that prescription within the high-intensity domain extends a dose-
response relationship between training load (as determined by the manipulation of the above variables) and 
physiological adaptation due to the greater demands placed on various systems involved with high intensity 
exercise 26. Considering this, the low overall training load of the short duration HIIE program reported by 
Schmitt et al. 16 (8x1min) compared to the present protocol (4x4min), may explain the lack of V̇O2peak change 
observed by this group, which is in contrast to the findings of the present study. Two longer duration trials that 
reported similar improvements between higher and lower intensity interventions gradually increased from a 
lower HIIE frequency (2.week-1) 14 and intensity (intervals ranging from 50-75% V̇O2peak) 13 than the present 
trial. Additionally, Martin et al. 15 did not find any differences using a higher-intensity continuous rather than 
interval prescription (75-80% HR at V̇O2peak). However, the exercise intensity of the lower intensity group was 
only 9% less than the higher intensity group; this may have been insufficient to elicit differences in adaptations 
between the intensities. Therefore, the total load of these higher intensity prescriptions may have been 
insufficient, when compared to both the physiological stimulus of the parallel low-moderate intensity 
prescriptions and current HIIE protocol, to promote superior improvements in V̇O2peak. It appears that the total 
training volume is key to the initial acquisition of V̇O2peak changes, which may explain why accelerated and 
superior improvements were observed in the present trial. 
Following accrual of changes in V̇O2peak in response to high-load HIIE, a tapered training frequency was 
investigated as a potentially effective strategy to maintain exercise-induced adaptations. Tapering of training 
frequency is widely used to maximise athletic performance in advance of competition, whilst also being shown 
to maintain improvements in V̇O2peak 19. In the oncology setting, maintenance of adaptations with a decreased 
training frequency may have important implications for long-term exercise adherence. Despite the training 
frequency of the HIIE-T group being two-thirds lower than that of the HIIE group from weeks four to eight, 
there were no significant differences (p≥0.05) in V̇O2peak between the groups at any time point. The V̇O2peak 
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improvements following four weeks without training were also superior to the MICE group (HIIE, p=0.006; 
HIIE-T, p=0.013), indicating similar improvements between the HIIE groups. This is a particularly important 
finding as ‘lack of time’ is a commonly reported barrier to maintaining adequate physical activity levels for 
colorectal cancer survivors 17. This is further supported in the present trial where the most commonly cited 
reason for non-participation was due to the ‘time or travel commitment’ (57.5%). These data suggest that 
improvements in V̇O2peak can be effectively maintained with a substantially reduced HIIE session requirement, 
which may help address one of the most commonly perceived barriers to physical activity for colorectal cancer 
survivors. This reduced training requirement may also have important implications for maintaining V̇O2peak 
during periods of additional cancer- or comorbidity-related treatments. 
The present data support the design of clinical exercise programs that include an initial acute block of high load 
(3 sessions.week-1) HIIE training to provide significant improvements in V̇O2peak followed by a maintenance 
period of reduced frequency of HIIE. Whilst this study only included a relatively short four-week period of 
tapered training, Martin et al. 15 demonstrated that clinic-based improvements in V̇O2peak were effectively 
maintained with an individualised home based program over a four-month follow up in participants who 
completed 8 weeks (3 sessions.week-1) of higher intensity exercise (75-80% HR at V̇O2peak); participants who 
completed low intensity exercise (60-65% HR at V̇O2peak) regressed to baseline over the same timeframe. 
Whether or not maintenance of V̇O2peak with reduced training lasts beyond four weeks remains to be 
established.  
Maintenance of V̇O2peak changes following the withdrawal of the training stimulus appears to be intensity 
specific. Both HIIE groups maintained an elevated V̇O2peak significantly above baseline and the MICE group 
after a four-week period without training, whereas results from participants in the MICE group were not 
different from baseline. This finding extends the work of Martin et al. 15 and shows that V̇O2peak improvements 
can be maintained, at least in the short term, even without an additional training stimulus. The mechanisms that 
explain this differential V̇O2peak maintenance between intensities are yet to be determined, however they may 
be specific to the primary location of adaptations [i.e. central (cardiovascular) versus peripheral (skeletal 
muscle)]. Future research is needed to investigate the specific improvements responsible for changes in 
V̇O2peak to better understand the mechanisms explaining the differential velocity, magnitude and maintenance 
of these changes between exercise intensities. Particularly if differential adaptations are indeed responsible for 
V̇O2peak changes following HIIE and MICE, a more specific understanding of tumour and treatment related 
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physiological impairments that underscore global reductions in V̇O2peak will facilitate the development of 
patient-specific prescriptions to optimise the benefits of exercise for colorectal cancer survivors 25. 
All HIIE and MICE interventions were found to maintain lean mass. Very few trials have investigated changes 
in lean mass in colorectal cancer survivors following exercise. These trials have also demonstrated similar 
findings in lean mass following a supervised 27 and a home based 28 combined aerobic and resistance based 
program. A lack of improvements in lean mass in the present trial are likely explainable by the absence of 
anabolic-specific resistance training. In contrast, a lack of change in studies including resistance training is 
intriguing when considering that these populations may be more sensitive to skeletal muscle anabolism given 
the atrophy that can occur with colorectal cancer treatment 29, 30. Given resistance training constitutes an 
important component of the exercise guidelines for cancer survivors, further research is warranted to better 
understand the anabolic responses to various exercise prescriptions in colorectal cancer survivors. The absence 
of anabolic improvements may have been further compounded by a lack of any post-exercise dietary 
recommendations. Recent recommendations suggest that older adults may require up to 40g.kg-1 body weight of 
dietary protein (double the requirement of younger adults) following resistance-based exercise to optimise post-
exercise protein synthesis 31. Whether hypertrophic adaptations following HIIE could be facilitated with acute 
post-exercise protein intake remains to be determined. 
HIIE significantly reduced fat mass compared to the MICE group following eight weeks of training (-0.7kg; 
p=0.038); these greater reductions were also maintained following withdrawal of the training intervention (-
0.7kg; p=0.045). Despite only a relatively modest reduction in fat mass from baseline in the HIIE group (-
1.1kg), a systematic review conducted in prostate cancer survivors has shown that exercise trials in isolation 
often fail to consistently promote reductions in fat mass 32. Similarly, previous comparative trials of exercise 
intensity on body composition in cancer survivors have generally found no differences between interventions 13, 
14, 16
, further underlying the importance of the present findings. Whilst the bioenergetics of MICE promotes 
greater utilisation of fatty acids as a substrate for energy provision during exercise 33, HIIE has been associated 
with greater post-exercise fat oxidation, a factor that may explain the present findings 34, 35. Higher intensity 
exercise has been shown to evoke significantly higher rates of oxygen consumption and subsequent fat 
oxidation compared to lower intensity exercise up to 40 minutes post-exercise in healthy young adults 36. 
However other studies have shown non-significant differences in both net oxygen consumption (intra- and three 
hour post-exercise) 37 and 24-hour energy expenditure 38 following HIIE and MICE in healthy young males, 
suggesting additional factors may underscore the differences in fat mass changes between HIIE and MICE 
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beyond intra- and post-exercise energy expenditure. Increases in resting energy expenditure have been 
suggested as an additional mechanism contributing to superior reductions in fat mass following HIIE 37, 39. In 
particular, resting energy expenditure has been shown to be elevated up to 19 hours following 40-minutes of 
moderate-vigorous aerobic exercise (~80% HRpeak) 39. Increases in the rate of resting energy expenditure were 
linearly related to the intensity of exercise (r=0.61, p<0.05) suggesting that higher intensity exercise may 
promote greater energy expenditure via prolonged increases in resting metabolic activity after the exercise bout 
39
. However, whether a similar phenomenon exists in cancer survivors and if this contributes to overall changes 
in fat mass following exercise at various intensities remains to be confirmed.  
In the only study to also measure body composition using DXA analysis, Schmitt et al. 16 did not find any 
significant differences in fat mass following a three-week intervention of HIIE (8x1min; >95% HRpeak; 3 
sessions.week-1) and MICE (75min; 60% HRpeak; 2 sessions.week-1). Despite differences in the intervention 
duration to the current study (3 vs. 8 weeks), the similar weekly volume of the MICE interventions (duration 
equivalent with current exercise oncology guidelines) suggests that the use of longer intervals (4 minutes) than 
used by Schmitt et al. 16 was important in promoting superior reductions in fat mass in the present trial. 
Therefore, increasing exercise intensity in isolation does not appear sufficient to promote superior changes in fat 
mass to that of moderate intensity exercise, with the duration of HIIE (and the subsequent effects on energy 
expenditure) appearing to also mediate this relationship. In addition to these prescriptive factors (intensity and 
duration), the present data also suggest a dose-response relationship between frequency of HIIE and fat mass 
reductions. Despite similar responses between HIIE and HIIE-T after four weeks of training (when the 
interventions were equivalent), only the higher exercise frequency, and therefore greater occurrence of intra- 
and post-exercise fat oxidation in the HIIE group led to superior reductions in fat mass compared to the MICE 
group following eight weeks of training and withdrawal of training. Hence, the use of a tapering strategy when 
prescribing HIIE for fat mass loss does not appear to offer the same effectiveness as when used for V̇O2peak 
outcomes. Therefore, if the outcome goal of an exercise intervention is to promote concurrent improvements in 
V̇O2peak as well as reductions in fat mass using HIIE, specific consideration of the exercise duration and 
frequency is required when determining the most appropriate prescription to optimise these improvements for 
colorectal cancer survivors.   
Whilst this study has demonstrated important relationships between exercise intensity and cardiorespiratory 
fitness and body composition, there are several limitations worthy of comment. Firstly these data come from a 
relatively small sample of colorectal cancer survivors, and as such these preliminary findings require additional 
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study from larger cohorts to confirm the present results. The sample size for body composition analyses was 
further reduced (n=10 consecutive participants, HIIE=3, HIIE-T=5, MICE=2) due to equipment malfunction, 
which may have influenced the observed changes in body composition. Secondly our follow up period was 
relatively short (four weeks) so it is difficult to speculate on the longevity of adaptations beyond this time point. 
Future trials are necessary to determine the complete duration of maintenance of improvements, and whether 
additional adjunctive prescriptions can further bolster this maintenance. It was also evident that despite 
stratification by sex, there were fewer female participants randomised into the HIIE group. Regardless, the 
inclusion of sex as a covariate in the analysis revealed no significant effects for any of the outcomes, indicating 
that this imbalance following randomisation likely did not impact the outcomes. Additionally, beyond 
instructions to participants to maintain their usual dietary habits, it is not possible to completely exclude the 
possibility that alterations in dietary intake throughout the intervention may have influenced changes in fat mass 
or contributed to the lack of changes in lean mass.  
In addition to previous data 12, the safety, high rates of completion, attendance, and adherence to the prescribed 
exercise intensity and duration for both HIIE and MICE programs supports the feasibility of these interventions 
within the supervised clinical setting. However, these data may overestimate the feasibility of HIIE and MICE 
programs in the community setting given the high proportion of participants that declined to participate given 
the travel and time commitments of this supervised clinical program. Whilst these results are encouraging based 
on the clinical efficacy of HIIE interventions, further research is undoubtedly required to determine the wider 
feasibility and subsequent efficacy and potential clinical utility of these interventions in the community setting 
40
.  
Finally the use of V̇O2peak in the present trial may have underestimated the heart rate intensity prescriptions. 
V̇O2max is defined as an individual’s maximal aerobic capacity, however due to difficulties in achieving this 
true maximum, V̇O2peak is often used to describe the maximal observed V̇O2 in a symptom limited exercise test 
to volitional fatigue 41. Particularly in individuals unfamiliar with strenuous exercise, V̇O2peak testing to 
volitional fatigue may underestimate true capacity 42. However the mean achieved RER of 1.23 in the present 
trial (an RER > 1.10 is recommended as an accurate and reliable measure of subject exertion 41) during V̇O2peak 
testing tends to support the conclusion that maximal exertion was achieved in these tests. Additionally there 
were no significant changes in RER across the intervention (baseline = 1.22; midpoint = 1.23; endpoint = 1.23; 
follow-up = 1.24; p = 0.506), which suggests comparable levels of maximal exertion across the intervention and 
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supports the observed changes being the result of the intervention rather than due to a learning effect of 
exercising to volitional fatigue 41. 
Conclusions 
In conclusion, the present study found greater improvements in V̇O2peak and reductions in fat mass following 
eight weeks of thrice-weekly HIIE when compared to the current aerobic moderate-intensity exercise oncology 
guidelines for cancer survivors. Based on the observed superior and accelerated benefits in cardiorespiratory 
fitness, HIIE interventions may promote clinically meaningful improvements more efficiently and effectively 
than programs implementing current aerobic exercise recommendations for cancer survivors, however this 
remains to be confirmed with larger sample sizes. Furthermore these preliminary findings indicate that 
prescription of HIIE appears to offer greater programming flexibility and a decreased training burden, with 
improvements in cardiorespiratory fitness being accrued even following a reduced frequency of training and 
maintained even after four weeks of complete withdrawal of exercise training. These findings are important, as 
HIIE may be an effective strategy to address the physiological regressions that occur as a result of interruptions 
and poor adherence to long-term exercise programs. This study has provided substantial novel insight for the 
design and prescription of exercise-medicine programs including HIIE to promote greater health outcomes for 
colorectal cancer survivors.  
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Table 1: Participant characteristics 
 All  HIIE  HIIE-T  MICE  
n  57  18  20  19  
Age (years) 60.7  ± 10.9 60.7  ± 11.7 61.5  ± 10.2 59.8  ± 11.4 
Body mass (kg) 80.6  ± 17.8 90.2  ± 12.5 73.8  ± 18.1 78.6  ± 18.5 
Body Mass Index (kg.m-2) 26.9  ± 4.5 29.8 ± 3.6 24.7 ± 4.5 26.5  ± 3.9 
Women [n (%)] 25 (41.0) 5 (27.8) 10 (50.0) 10 (52.6) 
Cancer History         
Colon cancer [n (%)] 41 (71.9) 12 (66.7) 14 (70.0) 15 (78.9) 
Rectal cancer [n (%)] 16 (28.1) 6 (33.3) 6 (30.0) 4 (21.1) 
Time since diagnosis (years) 4.1 ± 2.5 3.4 ± 2.2 4.6 ± 2.9 4.3 ± 2.3 
Time since treatment (years) 3.4 ± 2.6 2.6 ± 2.3 4.1 ± 3.1 3.3 ± 2.3 
Cancer Stage [n (%)]         
I 10 (17.5) 2 (11.1) 4 (20.0) 4 (21.1) 
II A 7 (12.3) 3 (16.7) 1 (5.0) 3 (15.8) 
II B 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
III A 5 (8.8) 1 (5.6) 2 (10.0) 2 (10.5) 
III B 11 (19.3) 5 (27.8) 1 (5.0) 5 (26.3) 
III C 4 (7.0) 0 (0.0) 4 (20.0) 0 (0.0) 
IV 5 (8.8) 3 (16.7) 1 (5.0) 1 (5.3) 
Unknown 15 (26.3 4 (22.2) 7 (35.0) 4 (21.1) 
Cancer Treatment [n (%)]         
Surgery  20 (35.1) 7 (38.9) 6 (30.0) 7 (36.8) 
Surgery & chemotherapy  29 (50.9) 9 (50.0) 11 (55.0) 9 (47.4) 
Surgery & radiation  2 (3.5) 0 (0) 2 (10.0) 0 (0) 
Surgery, chemotherapy & 
radiation 
5 (8.8) 2 (11.1) 0 (0) 3 (15.8) 
Radiation & chemotherapy  1 (1.8) 0 (0) 1 (5.0) 0 (0) 
Ethnicity [n (%)]         
Caucasian  54 (94.7) 17 (94.4) 19 (95.0) 18 (94.7) 
Asian 2 (3.6) 0 (0) 1 (5.0) 1 (5.3) 
African 1 (1.8) 1 (5.6) 0 (0) 0 (0) 
Smoking History [n (%)]         
Never 30 (52.6) 7 (38.9) 13 (65.0) 10 (52.6) 
Former 27 (47.4) 11 (61.1) 7 (35.0) 9 (47.4) 
Current 0 (0) 0 (0) 0 (0) 0 (0) 
Education [n (%)]         
Primary 4 (7.0) 1 (5.6) 2 (10.0) 1 (5.3) 
Secondary 18 (30.6) 8 (44.4) 1 (5.0) 9 (47.4) 
Trade 14 (24.6) 2 (11.1) 8 (45.0) 3 (15.8) 
University 21 (36.8) 7 (38.9) 9 (40.0) 6 (31.6) 
Marital Status [n (%)]         
Not-married 1 (1.8) 0 (0) 1 (5.0) 0 (0) 
Married 50 (87.8) 17 (94.4) 18 (90.0) 15 (78.9) 
Divorced/separated 6 (10.6) 1 (5.6) 1 (5.0) 4 (21.1) 
Employment [n (%)]         
Working 30 (52.6) 9 (50.0) 9 (45.0) 12 (63.2) 
Retired  27 (46.4) 9 (50.0) 11 (55.0) 7 (36.8) 
Intervention adherence          
Attendance (% prescribed) -  99.3 ± 2.2 99.9 ± 0.5 100.0 ± 0.0 
Duration (% prescribed) -  99.8 ± 0.4 100.0 ± 0.0 100.0 ± 0.0 
Peak HRa (% HRpeak) -  90.6 ± 3.7 90.7 ± 4.3 71.4 ± 8.3 
Continuous variables are presented as mean ± SD; Nominal values are presented as n (%) 
a
 Average of peak HR recorded across the four HIIE intervals or at 15, 30,40 and 50 minutes during MICE 
HIIE: High-intensity interval exercise; HIIE-T: High-intensity interval exercise – tapered; HRpeak: peak heart rate; 
MICE: Moderate-intensity continuous exercise 
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Table 2: Cardiorespiratory fitness outcome measures across the intervention 
 0 weeks (Baseline) 4 weeks (Midpoint) 8 weeks (Endpoint) 12 weeks (Follow up) 
V̇O2peak (ml·kg-1·min-1) Mean 95% CI p  Mean 95% CI p (0 vs. 4)a Mean 95% CI p (4 vs. 8) p (0 vs. 8) Mean 95% CI p (8 vs. 12) p (0 vs. 12) 
HIIE (n = 16) 23.2 21.8-24.5 - 27.4 26.0-28.8 p < 0.001 28.4 27.1-29.8 p = 0.349 p < 0.001 27.4 25.9-28.8 p = 0.349 p < 0.001 
HIIE-T (n = 16) 23.5 22.2-24.8 - 26.8 25.5-28.1 p < 0.001 27.6 26.3-29.0 p = 0.534 p < 0.001 26.9 25.5-28.2 p = 0.534 p < 0.001 
MICE (n = 15) 23.4 22.1-24.7 - 24.5 23.1-25.8 p = 0.327 26.1 24.8-27.4 p = 0.054 p < 0.001 24.1 22.6-25.5 p = 0.032 p = 0.689 
Between group differences p (0)b   p (4)   p (8)    p (12)  
HIIE vs. MICE -0.2 -2.2-1.8 p = 1.000 3.0 0.6-5.3 p = 0.008 2.3 0.0-4.7 p = 0.049 - 3.3 0.8-5.8 p = 0.006 - 
HIIE-T vs. MICE 0.1 -1.8-2.0 p = 1.000 2.3 0.2-4.5 p = 0.030 1.5 -0.6-3.7 p = 0.210 - 2.8 0.5-5.1 p = 0.013 - 
HIIE vs. HIIE-T -0.3 -2.7-2.0 p = 1.000 0.6 -1.3-2.6 p = 0.528 0.8 -1.1-2.7 p = 0.422 - 0.5 -1.5-2.5 p = 0.637 - 
 
              
a
 Within-group comparisons between the designated weeks of the intervention 
b
 Between-group comparisons at the designated week of the intervention 
Linear mixed modelling analysis; fixed factors: group, time, group x time; fixed covariates: sex, baseline variable score; random factors: participants 
Data from six participants were excluded from V̇O2peak analysis due to inabilities in completing a valid test (HIIE = 1; HIIE-T = 2; MICE = 2). Additionally, data from one participant in the HIIE-T group was 
excluded as an outlier, as the participant was substantially fitter than the average of the cohort (V̇O2peak = 53.9 ml.kg-1.min-1, cohort mean = 23.3 ml.kg-1.min-1). 
HIIE: High intensity interval exercise; HIIE-T: High intensity interval exercise – tapered; MICE: moderate intensity continuous exercise; V̇O2peak: peak oxygen uptake 
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Table 3: Body composition outcome measures across the intervention 
 0 weeks (Baseline) 4 weeks (Midpoint) 8 weeks (Endpoint) 12 weeks (Follow up) 
Lean mass (kg) Mean 95% CI p  Mean 95% CI p (0 vs. 4)a Mean 95% CI p (4 vs. 8) p (0 vs. 8) Mean 95% CI p (8 vs. 12) p (0 vs. 12) 
HIIE (n = 14) 45.1 44.6-45.6 - 45.7 45.2-46.2 p = 0.075 45.6 45.1-46.1 p = 1.000 p = 0.141 45.6 45.0-46.1 p = 1.000 p = 0.269 
HIIE-T (n = 14) 45.1 44.6-45.5 - 45.5 45.0-46.0 p = 0.665 45.5 45.0-46.0 p = 1.000 p = 0.682 45.4 44.9-46.0 p = 1.000 p = 0.730 
MICE (n = 15) 45.0 44.6-45.5 - 45.4 44.9-45.9 p = 0.522 45.6 45.1-46.1 p = 0.841 p = 0.157 45.8 45.3-46.3 p = 0.841 p = 0.027 
Between group differences p (0)b   p (4)   p (8)    p (12)  
HIIE vs. MICE 0.0 -0.8-0.9 p = 1.000 0.3 -0.5-1.2 p = 1.000 0.1 -0.7-0.8 p = 1.000 - -0.2 -1.1-0.6 p = 1.000 - 
HIIE-T vs. MICE 0.0 -0.6-0.7 p = 1.000 0.1 -0.6-0.8 p = 1.000 -0.1 -0.9-0.6 p = 1.000 - -0.4 -1.3-0.5 p = 0.910 - 
HIIE vs. HIIE-T 0.0 -0.7-0.7 p = 1.000 0.2 -0.6-1.1 p = 1.000 0.2 -0.7-1.1 p = 1.000 - 0.1 -0.7-0.1 p = 0.938 - 
 
              
Fat mass (kg) Mean 95% CI p  Mean 95% CI p (0 vs. 4)a Mean 95% CI p (4 vs. 8) p (0 vs. 8) Mean 95% CI p (8 vs. 12) p (0 vs. 12) 
HIIE (n = 14) 26.4 26.0-26.8 - 25.7 25.3-26.1 p = 0.006 25.3 24.9-25.7 p = 0.138 p < 0.001 25.4 25.0-25.8 p = 0.554 p < 0.001 
HIIE-T (n = 14) 26.3 25.9-26.7 - 25.7 25.3-26.1 p = 0.021 25.6 25.2-26.0 p = 1.000 p = 0.004 25.5 25.1-26.0 p = 1.000 p = 0.004 
MICE (n = 15) 26.3 25.9-26.6 - 26.1 25.7-26.5 p = 1.000 26.0 25.6-26.3 p = 1.000 p = 0.994 26.1 25.7-26.5 p = 1.000 p = 1.000 
Between group differences p (0)b   p (4)   p (8)    p (12)  
HIIE vs. MICE 0.1 -0.5-0.8 p = 1.000 -0.39 -1.0-0.3 p = 0.456 -0.7 -1.4-0.0 p = 0.038 - -0.7 -1.4-0.0 p = 0.045 - 
HIIE-T vs. MICE 0.1 -0.5-0.6 p = 1.000 -0.37 -1.0-0.3 p = 0.456 -0.4 -1.0-0.2 p = 0.324 - -0.6 -1.3-0.1 p = 0.082 - 
HIIE vs. HIIE-T 0.1 -0.5-0.7 p = 1.000 -0.02 -0.6-0.6 p = 0.948 -0.3 -0.9-0.2 p = 0.324 - -0.1 -0.7-0.5 p = 0.725 - 
a
 Within-group comparisons between the designated weeks of the intervention 
b
 Between-group comparisons at the designated week of the intervention 
Linear mixed modelling analysis; fixed factors: group, time, group x time; fixed covariates: sex, baseline variable score; random factors: participants 
Data from 10 consecutive participants (HIIE = 3, HIIE-T = 5, MICE = 2) were unavailable for analysis.  
HIIE: High intensity interval exercise; HIE-T: High intensity interval exercise - tapered MICE:  moderate intensity continuous exercise 
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Assessed for eligibility (n = 184) 
Randomized (n = 57) 
Allocated to HIIE (n =18) 
• Received allocated 
intervention (n = 17) 
• Discontinued intervention 
(n = 1) 
• Dropped out due to 
personal/family issues 
Allocated to MICE (n =19) 
• Received allocated 
intervention (n = 17) 
• Discontinued intervention 
(n = 2) 
• Dropped out due to 
personal/family issues 
Excluded (n = 127) 
• Medical condition/medication1 (n = 16) 
• Declined to participate (n = 30) 
• Travel & time commitment (n = 73) 
• Not interested in the type of exercise (n = 6) 
• Travelling (n = 2) 
Assessed at endpoint: 8 weeks 
(n = 17) 
Assessed at endpoint: 8 weeks 
 (n = 17) 
Enrollment 
Allocation 
Follow-up 
Follow-up 
Allocated to HIIE-T (n =20) 
• Received allocated 
intervention (n = 19) 
• Discontinued intervention 
(n = 1) 
• Ongoing diagnostic 
testing 
Assessed at endpoint: 8 weeks 
 (n = 19) 
Assessed at follow-up (n = 14) 
• n = 3 lost to follow-up 
• Travel/work 
commitments (n = 2) 
• Recurrence 
(metastasis)  (n = 1) 
 
Assessed at follow-up (n =14) 
• n = 3 lost to follow-up 
• Travel (n = 2) 
• Recurrence (local)  
(n = 1) 
 
Assessed at follow-up (n = 18) 
• n = 1 lost to follow-up 
• Travel (n = 1) 
 
Figure 1: CONSORT diagram illustrating participant flow through the intervention. 
1
 As part of specified exclusion criteria requiring screening on initial contact, other reasons were participant-
decided exclusions. 
HIIE: High intensity interval exercise; HIIE-T: High intensity interval exercise – tapered; MICE: moderate 
intensity continuous exercise. 
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